PHASE-I STUDY OF ORAL 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDINE (M-AMSA, NSC 249992)

被引：0
|
作者：
DEJAGER, R [1 ]
BODY, JJ [1 ]
DUPONT, D [1 ]
KLASTERSKY, J [1 ]
KENIS, Y [1 ]
机构：
[1] INST JULES BORDET,B-1000 BRUSSELS,BELGIUM
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1979年 / 20卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：429 / 429
页数：1
相关论文
共 50 条
  • [21] PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF 4'-(9-ACRIDINYLAMINO)-METHANESULFON-META-ANISIDIDE IN CHILDREN WITH CANCER
    RIVERA, G
    EVANS, WE
    DAHL, GV
    YEE, GC
    PRATT, CB
    CANCER RESEARCH, 1980, 40 (11) : 4250 - 4253
  • [22] ORAL ABSORPTION AND SELECTIVE TISSUE LOCALIZATION OF 4'-(9-ACRIDINYLAMINO)-METHANESULFON-M-ANISIDIDE
    CYSYK, RL
    SHOEMAKER, DD
    AYERS, OC
    ADAMSON, RH
    PHARMACOLOGY, 1978, 16 (04) : 206 - 213
  • [23] THE PRODUCTION OF TOPOISOMERASE-II-MEDIATED DNA CLEAVAGE IN HUMAN-LEUKEMIA CELLS PREDICTS THEIR SUSCEPTIBILITY TO 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (M-AMSA)
    BAKIC, M
    BERAN, M
    ANDERSSON, BS
    SILBERMAN, L
    ESTEY, E
    ZWELLING, LA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 134 (02) : 638 - 645
  • [24] TREATMENT OF REFRACTORY ADULT LYMPHOBLASTIC-LEUKEMIA (ALL) WITH 4'(9-ACRIDINYLAMINO) METHANESULFON-M-ANISIDIDE (AMSA)
    ARLIN, ZA
    FANUCCHI, MP
    GEE, TS
    KEMPIN, SJ
    MERTELSMANN, R
    YOUNG, CW
    CLARKSON, BD
    BLOOD, 1982, 60 (05) : 1224 - 1226
  • [25] PHASE II TRIAL OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (AMSA) IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    VANECHO, DA
    MARKUS, S
    AISNER, J
    WIERNIK, PH
    CANCER TREATMENT REPORTS, 1980, 64 (8-9): : 1009 - 1010
  • [26] EFFICACY AND TOXICITY OF METHANESULFON-META-ANISIDINE, 4'-(9-ACRIDINYLAMINO) 24992) (META-AMSA) IN ADVANCED CHILDHOOD LEUKEMIA
    LAND, VJ
    CIVIN, CI
    RAGAB, AH
    MAHONEY, DH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 403 - 403
  • [27] PHASE-II EVALUATION OF 4'-(9-ACRIDINYLAMINO)-METHANESULFON-M-ANISIDIDE (AMSA) IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA
    CARROLL, DS
    KEMENY, N
    LYNCH, G
    WOODCOCK, T
    CANCER TREATMENT REPORTS, 1980, 64 (10-1): : 1149 - 1150
  • [28] NEUROLOGIC AND CARDIAC-RHYTHM ABNORMALITIES ASSOCIATED WITH 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (AMSA) THERAPY
    LEGHA, SS
    LATREILLE, J
    MCCREDIE, KB
    BODEY, GP
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 2001 - 2003
  • [29] PHASE-II STUDY OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (AMSA) IN OVARIAN-CARCINOMA, HYPER-NEPHROMA, AND MELANOMA
    AMREIN, PC
    POULIN, RF
    RICHARDS, F
    CAREY, RW
    COLEMAN, M
    RAFLA, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 531 - 531
  • [30] PHASE-I AND PHASE-II STUDIES WITH M-AMSA
    WEIL, M
    AUCLERC, MF
    AUCLERC, G
    JACQUILLAT, C
    SCHAISON, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 360 - 360
12345